Evidence map›Paper›PMID 24823811›Full record

ArticleJournal of leukocyte biology2014

Technical advance: liposomal alendronate depletes monocytes and macrophages in the nonhuman primate model of human disease.

Benjamin J Burwitz, Jason S Reed, Katherine B Hammond, Merete A Ohme, Shannon L Planer, Alfred W Legasse, Adam J Ericsen, Yoram Richter, Gershon Golomb, Jonah B Sacha

Abstract read
In one paragraph

Article in Journal of leukocyte biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. In vitro potency, in vitro and in vivo efficacy of liposomal alendronate in combination with γδ T cell immunotherapy in mice.Journal of controlled release : official journal of the Controlled Release Society · 2016
    Article
  8. Strategies to target non-T-cell HIV reservoirs.Current opinion in HIV and AIDS · 2016
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Benjamin J BurwitzVaccine and Gene Therapy Institute and Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA;
Jason S ReedVaccine and Gene Therapy Institute and Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA;
Katherine B HammondVaccine and Gene Therapy Institute and Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA;
Merete A OhmeDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA;
Shannon L PlanerDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA;
Alfred W LegasseDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA;
Adam J EricsenDepartment of Pathology, University of Wisconsin-Madison, Madison, Wisconsin, USA;
Yoram RichterBioRest, Tel Aviv, Israel; and.
Gershon GolombInstitute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Israel.
Jonah B SachaVaccine and Gene Therapy Institute and Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA; sacha@ohsu.edu.
Oregon Health & Science University · USVaccine and Gene Therapy InstituteChildren's Cancer Therapy Development Institute · USHebrew University of Jerusalem · ILOregon National Primate Research Center · USUniversity of Wisconsin–Madison · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Nonhuman Primate Reagent ResourceU24AI126683 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Diogo Magnani · 2016 to 2026
$20.1M
Viral Testing CoreU42OD010426 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Gregory A Dissen · 2013 to 2026
$6.0M
Resource for Nonhuman Primate Cell Depleting AntibodiesR24OD010976 · OD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ENGELMAN, KATHLEEN, MAGNANI, DIOGO · 2012 to 2019
$4.7M
NIAID NIH HHS HHSN272200900037CNIAID NIH HHS P30 AI027763NIAID NIH HHS U24 AI126683NIH HHS OD010976NIH HHS P51 OD011092NIH HHS R24 OD010976NIH HHS U42 OD010426PHS HHS HHSN272200090037C
6 · The paper itself

Abstract

Nonhuman primates are critical animal models for the study of human disorders and disease and offer a platform to assess the role of immune cells in pathogenesis via depletion of specific cellular subsets. However, this model is currently hindered by the lack of reagents that safely and specifically ablate myeloid cells of the monocyte/macrophage Lin. Given the central importance of macrophages in homeostasis and host immunity, development of a macrophage-depletion technique in nonhuman primates would open new avenues of research. Here, using LA at i.v. doses as low as 0.1 mg/kg, we show a >50% transient depletion of circulating monocytes and tissue-resident macrophages in RMs by an 11-color flow cytometric analysis. Diminution of monocytes was followed rapidly by emigration of monocytes from the bone marrow, leading to a rebound of monocytes to baseline levels. Importantly, LA was well-tolerated, as no adverse effects or changes in gross organ function were observed during depletion. These results advance the ex vivo study of myeloid cells by flow cytometry and pave the way for in vivo studies of monocyte/macrophage biology in nonhuman primate models of human disease.

Indexed as

Disease Models, AnimalAlendronateAnimalsBone MarrowCell CountCell MovementCell SeparationDNA ReplicationDrug Evaluation, PreclinicalFlow CytometryHumansInjections, IntraperitonealInjections, IntravenousLiposomesMacaca mulattaMacrophagesAlendronateLiposomesbisphosphonatesmyeloid cells

Identifiers

PMID24823811
PMCPMC4632165
OpenAlexW2147288352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.